Drugs & Aging

, Volume 34, Issue 5, pp 411–411 | Cite as

Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis

  • Olivier Bruyère
  • Cyrus Cooper
  • Nigel Arden
  • Jaime Branco
  • Maria Luisa Brandi
  • Gabriel Herrero-Beaumont
  • Francis Berenbaum
  • Elaine Dennison
  • Jean-Pierre Devogelaer
  • Marc Hochberg
  • John Kanis
  • Andrea Laslop
  • Tim McAlindon
  • Susanne Reiter
  • Pascal Richette
  • René Rizzoli
  • Jean-Yves Reginster
Erratum
  • 500 Downloads

1 Erratum to: Drugs Aging (2015) 32:179–187 DOI 10.1007/s40266-015-0243-3

In the Original publication the affiliation for J. Kanis was incorrectly published.

This previously read: WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK.

Should read: Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK.

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  • Olivier Bruyère
    • 1
  • Cyrus Cooper
    • 2
    • 3
  • Nigel Arden
    • 2
    • 3
  • Jaime Branco
    • 4
  • Maria Luisa Brandi
    • 5
  • Gabriel Herrero-Beaumont
    • 6
  • Francis Berenbaum
    • 7
  • Elaine Dennison
    • 2
  • Jean-Pierre Devogelaer
    • 8
  • Marc Hochberg
    • 9
  • John Kanis
    • 10
  • Andrea Laslop
    • 11
  • Tim McAlindon
    • 12
  • Susanne Reiter
    • 13
  • Pascal Richette
    • 14
  • René Rizzoli
    • 15
  • Jean-Yves Reginster
    • 1
  1. 1.Department of Public Health, Epidemiology and Health EconomicsUniversity of LiègeLiègeBelgium
  2. 2.MRC Lifecourse Epidemiology Unit and NIHR Nutrition Biomedical Research CentreUniversity of SouthamptonSouthamptonUK
  3. 3.Oxford NIHR Musculoskeletal Biomedical Research UnitUniversity of OxfordOxfordUK
  4. 4.CEDOC, Department of Rheumatology, Faculdadede Ciências MédicasUniversidade Novade Lisboa, CHLO, EPE, Hospital Egas MonizLisbonPortugal
  5. 5.Metabolic Bone Unit, Department of Surgery and Translational MedicineUniversity of FlorenceFlorenceItaly
  6. 6.Department of Rheumatology, Bone and Joint Research UnitIIS-Fundación Jiménez Díaz, UAM, Fundación Jiménez DíazMadridSpain
  7. 7.Department of Rheumatology, AP-HPSaint-Antoine Hospital, Pierre and Marie Curie UniversityParisFrance
  8. 8.Department of RheumatologySaint-Luc University Hospital, Université Catholique de LouvainBrusselsBelgium
  9. 9.Departments of Medicine and Epidemiology and Public HealthUniversity of Maryland School of MedicineBaltimoreUSA
  10. 10.Centre for Metabolic Bone DiseasesUniversity of Sheffield Medical SchoolSheffieldUK
  11. 11.Scientific OfficeAustrian Agency for Health and Food Safety (AGES)ViennaAustria
  12. 12.Division of RheumatologyTufts Medical CenterBostonUSA
  13. 13.Bundesinstitut für Arzneimittel und MedizinprodukteBonnGermany
  14. 14.Université Paris 7, UFR médicale, Assistance Publique-Hôpitaux de Paris, Hôpital Lariboisière, Fédération de RhumatologieParis CedexFrance
  15. 15.Division of Bone DiseasesGeneva University Hospital and Faculty of MedicineGenevaSwitzerland

Personalised recommendations